Waiver Agreement between Todos Medical Ltd. and Yozma Global Genomic Fund 1 (March 2021)
Todos Medical Ltd. and Yozma Global Genomic Fund 1 have agreed that Yozma permanently waives its right under their Securities Purchase Agreement to designate a member to Todos Medical's Board. This waiver is effective forever, and Yozma will no longer have board designation rights. The agreement is signed by representatives of both parties.
Exhibit 10.1
Waiver Agreement
Pursuant to Section 5.5 of the Securities Purchase Agreement (the “Agreement”) dated January 22, 2021 between Todos Medical Ltd. and Yozma Global Genomic Fund 1 (“Yozma”), Yozma hereby waives Section 4.22 of the Agreement in perpetuity and agrees that it will not be entitled to designate anyone as its Board designee. Capitalized terms not defined herein shall have the meanings assigned to them in the Agreement.
| Yozma Global Genomic Fund 1 | ||
| By: | /s/ Wonjae Lee | |
| Name: | Wonjae Lee | |
| Title: | Representative fund manager | |
| Accepted and Acknowledged by: | |||
| Todos Medical Ltd. | |||
| By: | /s/ Gerald Commissiong | 3/21/2021 | |
| Name: | Gerald Commissiong | ||
| Title: | CEO | ||
| -1- |
